Search Login Register

Cortical Blindness (Anton Syndrome) Summary

Description: Total loss of vision in all or part of the visual field due to bilateral OCCIPITAL LOBE (i.e., VISUAL CORTEX) damage or dysfunction. Anton syndrome is characterized by the psychic denial of true, organic cortical blindness. (Adams et al., Principles of Neurology, 6th ed, p460)

Also Known As: Anton Syndrome; Syndrome, Anton; Blindness, Cortical; Anton's Syndrome; Anton-Babinski Syndrome Show All >>

Networked: 169 relevant articles (3 outcomes, 6 trials/studies) for this Disease

Key Drugs and Agents for Cortical Blindness

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cyclosporine (Ciclosporin) : 1 outcome in 22 results : FDA 20 Generic
  2. Carbon Monoxide : 1 outcome in 3 results : IBA
  3. Anti-Bacterial Agents (Antibiotics) : 1 outcome in 1 result : IBA
  4. Contrast Media : 1 study in 8 results : IBA
  5. Silver : 1 study in 1 result : IBA
  6. iobitridol : 1 study in 1 result : IBA
  7. Retinaldehyde (Retinal) : 11 results : IBA
  8. Cisplatin (Platino) : 8 results : FDA 6 Generic
  9. Tacrolimus (Prograf) : 3 results : FDA 7 Generic
  10. Vincristine (Oncovin) : 3 results : FDA 17 Generic
Show All >>

Diseases Related to Cortical Blindness

  1. Acute Kidney Injury (Acute Renal Failure)
  2. Pneumonia (Pneumonitis)
  3. Seizures (Seizure)
  4. Coma (Comas)
  5. Neurofibromatoses (Neurofibromatosis)
Show All >>

Key Therapies for Cortical Blindness

Efficacy Chart >>
  1. Transplants (Transplant) : 2 studies in 17 results
  2. Drug Therapy (Chemotherapy) : 1 study in 7 results
  3. Angioplasty (Angioplasty, Transluminal) : 1 study in 2 results
  4. Phototherapy (Light Therapy) : 1 study in 1 result
  5. Catheters : 6 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.